Skip to main content
Clinical Trials/ISRCTN12911644
ISRCTN12911644
Completed
N/A

A pilot clinical trial to test the acceptability and feasibility of different doses of oral iron supplementation to prevent maternal anaemia - PANDA-Dose Study

HS Blood and Transplant0 sites300 target enrollmentApril 27, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Iron supplementation in pregnant women
Sponsor
HS Blood and Transplant
Enrollment
300
Status
Completed
Last Updated
last year

Overview

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39208353/ (added 02/09/2024)

Registry
who.int
Start Date
April 27, 2023
End Date
August 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
HS Blood and Transplant

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy non\-anaemic pregnant women of all parities (haemoglobin concentration (Hb) \> \= 110 g/l) at booking or screening.
  • 2\. 13 weeks \+ 6 days gestation or less
  • 3\. Age 18 and above
  • 4\. Able to give informed consent and willing to fulfil trial requirements

Exclusion Criteria

  • Women with the following conditions will be excluded:
  • 1\. Known haemoglobinopathies
  • 2\. Anaemia of any type, defined by BSH guidelines
  • 3\. Severe gastrointestinal disease, affecting tolerability of oral iron
  • 4\. Allergies to iron
  • 5\. Multiple pregnancies, given the higher iron demands
  • 6\. Known haemochromatosis
  • 7\. Recent red cell transfusion, within 1 month

Outcomes

Primary Outcomes

Not specified

Similar Trials